Condition
Denosumab Allergy
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Unknown1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05065164Phase 2WithdrawnPrimary
Denosumab and Screw Fixation for Osteoporotic Compression Fracture
NCT05662358Not ApplicableUnknownPrimary
Denosumab vs Alendronate After Vertebroplasty
NCT05598606Phase 4CompletedPrimary
Denosumab vs Zoledronate After Vertebroplasty
NCT05415657Not ApplicableCompleted
Denosumab Effect on Bone Quality and Function After Lumbar Fusion Surgery
Showing all 4 trials